Crystalys Therapeutics

San Diego, CA · Founded 2025 · Privately Held (backing)

Developer of innovative therapeutics designed to address the significant unmet medical needs of people living with gout. Crystalys Therapeutics is based in San Diego, CA and was founded in 2025. Its last reported valuation was $263 million in Sep 2025. It has raised $205 million.

Last reported valuation
$263.0M
Oct 2026
Priced at
—
Total raised
$205.0M
Last round
—

Who backs Crystalys Therapeutics?

15 investors
InvestorType
KB InvestmentVenture capital
Alexandria Venture InvestmentsOther
Novo HoldingsOther
Perceptive AdvisorsHedge fund
SR One Capital ManagementOther
Lightstone VenturesVenture capital
GoldenTree Asset ManagementAsset manager
Prebys VenturesOther
AN Ventures—
Aberdeen Investments (Scotland)—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Crystalys Therapeutics investors

15 investors are on record for Crystalys Therapeutics, including KB Investment, Alexandria Venture Investments, Novo Holdings and Perceptive Advisors.

Free account
More of Crystalys Therapeutics with a free account
  • ·The complete investor list: 15 names
  • ·Watch Crystalys Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like Crystalys Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View